Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GSK and J&J launch €150M VC fund with Index

This article was originally published in Scrip

Executive Summary

Pharma giants GlaxoSmithKline and Johnson & Johnson have validated the asset centric investment approach of venture capitalist Index Ventures by cornerstoning a new €150 million fund. The pharma companies have each taken a 25% stake in the exclusively life sciences fund, with longstanding Index limited partners taking up the rest. Crucially, management of the fund will be the responsibility of Index Ventures, the pharma partners will only have an advisory role.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts